Literature DB >> 3347020

A theory of blood flow in skeletal muscle.

G W Schmid-Schönbein1.   

Abstract

A theoretical analysis of blood flow in the microcirculation of skeletal muscle is provided. The flow in the microvessels of this organ is quasi steady and has a very low Reynolds number. The blood is non-Newtonian and the blood vessels are distensible with viscoelastic properties. A formulation of the problem is provided using a viscoelastic model for the vessel wall which was recently derived from measurements in the rat spinotrapezius muscle (Skalak and Schmid-Schönbein, 1986b). Closed form solutions are derived for several physiologically important cases, such as perfusion at steady state, transient and oscillatory flows. The results show that resting skeletal muscle has, over a wide range of perfusion pressures an almost linear pressure-flow curve. At low flow it exhibits nonlinearities. Vessel distensibility and the non-Newtonian properties of blood both have a strong influence on the shape of the pressure-flow curve. During oscillatory flow the muscle exhibits hysteresis. The theoretical results are in qualitative agreement with experimental observations.

Entities:  

Mesh:

Year:  1988        PMID: 3347020     DOI: 10.1115/1.3108401

Source DB:  PubMed          Journal:  J Biomech Eng        ISSN: 0148-0731            Impact factor:   2.097


  3 in total

1.  Effect of wall compliance and permeability on blood-flow rate in counter-current microvessels formed from anastomosis during tumor-induced angiogenesis.

Authors:  Peng Guo; Bingmei M Fu
Journal:  J Biomech Eng       Date:  2012-04       Impact factor: 2.097

2.  A high precision dual feedback pump for unsteady perfusion of small organs.

Authors:  D W Sutton; E H Mead; G W Schmid-Schönbein
Journal:  Ann Biomed Eng       Date:  1989       Impact factor: 3.934

3.  Wave transmission and input impedance of a model of skeletal muscle microvasculature.

Authors:  H F Frasch; J Y Kresh; A Noordergraaf
Journal:  Ann Biomed Eng       Date:  1994 Jan-Feb       Impact factor: 3.934

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.